-
Je něco špatně v tomto záznamu ?
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
L. Pagano, J. Salmanton-García, F. Marchesi, A. Busca, P. Corradini, M. Hoenigl, N. Klimko, P. Koehler, A. Pagliuca, F. Passamonti, L. Verga, B. Víšek, O. Ilhan, G. Nadali, B. Weinbergerová, R. Córdoba-Mascuñano, M. Marchetti, GP. Collins, F....
Jazyk angličtina Země Velká Británie
Typ dokumentu klinické zkoušky, časopisecké články, práce podpořená grantem
Grantová podpora
2020-8223
optics committm (covid-19 unmet medical needs and associated research extension) covid-19 rfp program by gilead science, united states
NLK
BioMedCentral
od 2008-12-01
BioMedCentral Open Access
od 2008
Directory of Open Access Journals
od 2008
Free Medical Journals
od 2008
PubMed Central
od 2008
Europe PubMed Central
od 2008
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2008-01-01
Open Access Digital Library
od 2008-01-01
Medline Complete (EBSCOhost)
od 2009-01-17
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2008
Springer Nature OA/Free Journals
od 2008-12-01
- MeSH
- COVID-19 komplikace diagnóza epidemiologie terapie MeSH
- dospělí MeSH
- hematologické nádory komplikace epidemiologie terapie MeSH
- hospitalizace MeSH
- jednotky intenzivní péče MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- registrace MeSH
- rizikové faktory MeSH
- SARS-CoV-2 izolace a purifikace MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- klinické zkoušky MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Evropa MeSH
BACKGROUND: Patients with hematological malignancies (HM) are at high risk of mortality from SARS-CoV-2 disease 2019 (COVID-19). A better understanding of risk factors for adverse outcomes may improve clinical management in these patients. We therefore studied baseline characteristics of HM patients developing COVID-19 and analyzed predictors of mortality. METHODS: The survey was supported by the Scientific Working Group Infection in Hematology of the European Hematology Association (EHA). Eligible for the analysis were adult patients with HM and laboratory-confirmed COVID-19 observed between March and December 2020. RESULTS: The study sample includes 3801 cases, represented by lymphoproliferative (mainly non-Hodgkin lymphoma n = 1084, myeloma n = 684 and chronic lymphoid leukemia n = 474) and myeloproliferative malignancies (mainly acute myeloid leukemia n = 497 and myelodysplastic syndromes n = 279). Severe/critical COVID-19 was observed in 63.8% of patients (n = 2425). Overall, 2778 (73.1%) of the patients were hospitalized, 689 (18.1%) of whom were admitted to intensive care units (ICUs). Overall, 1185 patients (31.2%) died. The primary cause of death was COVID-19 in 688 patients (58.1%), HM in 173 patients (14.6%), and a combination of both COVID-19 and progressing HM in 155 patients (13.1%). Highest mortality was observed in acute myeloid leukemia (199/497, 40%) and myelodysplastic syndromes (118/279, 42.3%). The mortality rate significantly decreased between the first COVID-19 wave (March-May 2020) and the second wave (October-December 2020) (581/1427, 40.7% vs. 439/1773, 24.8%, p value < 0.0001). In the multivariable analysis, age, active malignancy, chronic cardiac disease, liver disease, renal impairment, smoking history, and ICU stay correlated with mortality. Acute myeloid leukemia was a higher mortality risk than lymphoproliferative diseases. CONCLUSIONS: This survey confirms that COVID-19 patients with HM are at high risk of lethal complications. However, improved COVID-19 prevention has reduced mortality despite an increase in the number of reported cases.
Amsterdam UMC Location VUmc Amsterdam Netherlands
Ankara University Ankara Turkey
ASST Grande Ospedale Metropolitano Niguarda Milan Italy
ASST Spedali Civili Brescia Italy
Azienda Ospedaliera San Gerardo Monza Monza Italy
Azienda Sanitaria Universitaria del Friuli Centrale Udine Italy
Cell Therapy and Hematology San Bortolo Hospital Vicenza Italy
Centre Hospitalier de Versailles Versailles France
Centro de Investigación del Cáncer IBMCC Hospital Universitario de Salamanca IBSAL Salamanca Spain
Clinic of Hematology University Clinical Center of Serbia Belgrade Serbia
Clinical and Translational Fungal Working Group University of California San Diego La Jolla CA USA
Clinical Hematology Centro Hospitalar E Universitário São João Porto Portugal
Clinical Hematology Faculty of Medicine University of Porto Porto Portugal
Communicable Disease Center Hamad Medical Corporation Doha Qatar
Complejo Hospitalario de Navarra Iruña Pamplona Spain
Croatian Cooperative Group for Hematological Diseases Zagreb Croatia
Departament de Medicina Universitat Autònoma de Barcelona Bellaterra Spain
Department of Biomedicine and Prevention University of Rome Tor Vergata Rome Italy
Department of Hematological Medicine King's College Hospital NHS Foundation Trust London UK
Department of Hematology and Oncology Medical University of Innsbruck Innsbruck Austria
Department of Hematology University Hospital Dubrava Zagreb Croatia
Department of Infectious Diseases Karolinska University Hospital Stockholm Sweden
Ematologia Con Trapianto Ospedale Dimiccoli Barletta Barletta Italy
Faculty of Medicine and Faculty of Health Studies University of Rijeka Rijeka Croatia
Faculty of Medicine University of Belgrade Belgrade Serbia
Faculty of Medicine University of Zagreb Zagreb Croatia
Federal University of Rio de Janeiro Rio de Janeiro Brazil
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy
Fondazione IRCCS Istituto Nazionale Dei Tumori Milan Italy
Fundacion Jimenez Diaz University Hospital Health Research Institute IIS FJD Madrid Spain
Fundacion Jimenez Díaz University Hospital Health Research Institute IIS FJD Madrid Spain
German Centre for Infection Research Partner Site Bonn Cologne Cologne Germany
Gomel State Medical University Gomel Belarus
Haematology and Haemotherapy Department Hospital General Universitario Gregorio Marañón Madrid Spain
Hematology and Bone Marrow Transplantation IRCCS San Raffaele Scientific Institute Milan Italy
Hematology and Stem Cell Transplant Unit IRCCS Regina Elena National Cancer Institute Rome Italy
Hematology Department Hospital Universitario de Salamanca Salamanca Spain
Hematology Service Instituto Nacional Do Cancer Rio de Janeiro Brazil
Hematology Unit Center for Translational Medicine Azienda USL Toscana NordOvest Livorno Italy
Hospital Clinic Barcelona Spain
Hospital Escuela de Agudos Dr Ramón Madariaga Posadas Argentina
Hospital Rey Juan Carlos Móstoles Spain
Hospital Universitario 12 de Octubre Madrid Spain
Hospital Universitario Marqués de Valdecilla Santander Spain
Hospital Universitario Puerta de Hierro Majadahonda Spain
IBSAL Centro de Investigación del Cáncer IBMCC Salamanca Spain
Institute of Hematology and Blood Transfusion Prague Czech Republic
King's College Hospital London UK
King's College London London UK
La Paz University Hospital Madrid Spain
Marmara University Istanbul Turkey
National Center for Cancer Care and Research Hamad Medical Corporation Doha Qatar
NIHR Oxford Biomedical Research Centre Churchill Hospital Oxford UK
North Western State Medical University Named After Iliá Ilich Méchnikov Saint Petersburg Russia
Oncology Center Mansoura University Mansoura Egypt
Policlinico Borgo Roma Verona Verona Italy
Portuguese Institute of Oncology Lisbon Portugal
Rigshospitalet Copenhagen Denmark
S Instituto de Investigação E Inovação Em Saúde Universidade Do Porto Porto Portugal
San Luigi Gonzaga Hospital Orbassano Orbassano Italy
Scientific and Practical Center for Surgery Transplantology and Hematology Minsk Belarus
Stem Cell Transplant Center AOU Citta' Della Salute E Della Scienza Turin Italy
Sultan Qaboos University Hospital Muscat Oman
U O Ematologia E Centro Trapianti Midollo Osseo Ospedale Maggiore Parma Italy
Università Cattolica del Sacro Cuore Rome Italy
Università Milano Bicocca Milan Italy
University Hospital Centre Rijeka Rijeka Croatia
University Hospital Centre Zagreb Zagreb Croatia
University Hospital Hradec Králové Hradec Králové Czech Republic
University Hospital of Královské Vinohrady Prague Czech Republic
University Hospital Ostrava Ostrava Czech Republic
University Medical Center Groningen Groningen Netherlands
University of Milan and Fondazione IRCCS Istituto Nazionale Dei Tumori Milan Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22003459
- 003
- CZ-PrNML
- 005
- 20220127150217.0
- 007
- ta
- 008
- 220113s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s13045-021-01177-0 $2 doi
- 035 __
- $a (PubMed)34649563
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Pagano, Livio $u Hematology, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS - Università Cattolica del Sacro Cuore, Rome, Italy. Livio.Pagano@unicatt.it $u Università Cattolica del Sacro Cuore, Rome, Italy. Livio.Pagano@unicatt.it
- 245 10
- $a COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) / $c L. Pagano, J. Salmanton-García, F. Marchesi, A. Busca, P. Corradini, M. Hoenigl, N. Klimko, P. Koehler, A. Pagliuca, F. Passamonti, L. Verga, B. Víšek, O. Ilhan, G. Nadali, B. Weinbergerová, R. Córdoba-Mascuñano, M. Marchetti, GP. Collins, F. Farina, C. Cattaneo, A. Cabirta, M. Gomes-Silva, F. Itri, J. van Doesum, MP. Ledoux, M. Čerňan, O. Jakšić, RF. Duarte, G. Magliano, AS. Omrani, NS. Fracchiolla, A. Kulasekararaj, T. Valković, CB. Poulsen, M. Machado, A. Glenthøj, I. Stoma, Z. Ráčil, K. Piukovics, M. Navrátil, Z. Emarah, U. Sili, J. Maertens, O. Blennow, R. Bergantim, C. García-Vidal, L. Prezioso, A. Guidetti, MI. Del Principe, M. Popova, N. de Jonge, I. Ormazabal-Vélez, N. Fernández, I. Falces-Romero, A. Cuccaro, S. Meers, C. Buquicchio, D. Antić, M. Al-Khabori, R. García-Sanz, MM. Biernat, MC. Tisi, E. Sal, L. Rahimli, N. Čolović, M. Schönlein, M. Calbacho, C. Tascini, C. Miranda-Castillo, N. Khanna, GA. Méndez, V. Petzer, J. Novák, C. Besson, R. Duléry, S. Lamure, M. Nucci, G. Zambrotta, P. Žák, GC. Seval, V. Bonuomo, J. Mayer, A. López-García, MV. Sacchi, S. Booth, F. Ciceri, M. Oberti, M. Salvini, M. Izuzquiza, R. Nunes-Rodrigues, E. Ammatuna, A. Obr, R. Herbrecht, L. Núñez-Martín-Buitrago, V. Mancini, H. Shwaylia, M. Sciumè, J. Essame, M. Nygaard, J. Batinić, Y. Gonzaga, I. Regalado-Artamendi, LK. Karlsson, M. Shapetska, M. Hanakova, S. El-Ashwah, Z. Borbényi, GM. Çolak, A. Nordlander, G. Dragonetti, AME. Maraglino, A. Rinaldi, C. De Ramón-Sánchez, OA. Cornely, EPICOVIDEHA working group
- 520 9_
- $a BACKGROUND: Patients with hematological malignancies (HM) are at high risk of mortality from SARS-CoV-2 disease 2019 (COVID-19). A better understanding of risk factors for adverse outcomes may improve clinical management in these patients. We therefore studied baseline characteristics of HM patients developing COVID-19 and analyzed predictors of mortality. METHODS: The survey was supported by the Scientific Working Group Infection in Hematology of the European Hematology Association (EHA). Eligible for the analysis were adult patients with HM and laboratory-confirmed COVID-19 observed between March and December 2020. RESULTS: The study sample includes 3801 cases, represented by lymphoproliferative (mainly non-Hodgkin lymphoma n = 1084, myeloma n = 684 and chronic lymphoid leukemia n = 474) and myeloproliferative malignancies (mainly acute myeloid leukemia n = 497 and myelodysplastic syndromes n = 279). Severe/critical COVID-19 was observed in 63.8% of patients (n = 2425). Overall, 2778 (73.1%) of the patients were hospitalized, 689 (18.1%) of whom were admitted to intensive care units (ICUs). Overall, 1185 patients (31.2%) died. The primary cause of death was COVID-19 in 688 patients (58.1%), HM in 173 patients (14.6%), and a combination of both COVID-19 and progressing HM in 155 patients (13.1%). Highest mortality was observed in acute myeloid leukemia (199/497, 40%) and myelodysplastic syndromes (118/279, 42.3%). The mortality rate significantly decreased between the first COVID-19 wave (March-May 2020) and the second wave (October-December 2020) (581/1427, 40.7% vs. 439/1773, 24.8%, p value < 0.0001). In the multivariable analysis, age, active malignancy, chronic cardiac disease, liver disease, renal impairment, smoking history, and ICU stay correlated with mortality. Acute myeloid leukemia was a higher mortality risk than lymphoproliferative diseases. CONCLUSIONS: This survey confirms that COVID-19 patients with HM are at high risk of lethal complications. However, improved COVID-19 prevention has reduced mortality despite an increase in the number of reported cases.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a COVID-19 $x komplikace $x diagnóza $x epidemiologie $x terapie $7 D000086382
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a hematologické nádory $x komplikace $x epidemiologie $x terapie $7 D019337
- 650 _2
- $a hospitalizace $7 D006760
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a jednotky intenzivní péče $7 D007362
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a registrace $7 D012042
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a SARS-CoV-2 $x izolace a purifikace $7 D000086402
- 650 _2
- $a mladý dospělý $7 D055815
- 651 _2
- $a Evropa $x epidemiologie $7 D005060
- 655 _2
- $a klinické zkoušky $7 D016430
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Salmanton-García, Jon $u Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Excellence Center for Medical Mycology (ECMM), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany $u Cologne Excellence Cluster On Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany
- 700 1_
- $a Marchesi, Francesco $u Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
- 700 1_
- $a Busca, Alessandro $u Stem Cell Transplant Center, AOU Citta' Della Salute E Della Scienza, Turin, Italy
- 700 1_
- $a Corradini, Paolo $u University of Milan and Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy
- 700 1_
- $a Hoenigl, Martin $u Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, San Diego, CA, USA $u Clinical and Translational Fungal-Working Group, University of California San Diego, La Jolla, CA, USA $u Section of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Medical University of Graz, Graz, Austria
- 700 1_
- $a Klimko, Nikolai $u North-Western State Medical University Named After Iliá Ilich Méchnikov, Saint-Petersburg, Russia
- 700 1_
- $a Koehler, Philipp $u Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Excellence Center for Medical Mycology (ECMM), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany $u Cologne Excellence Cluster On Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany
- 700 1_
- $a Pagliuca, Antonio $u Department of Hematological Medicine, King's College Hospital NHS Foundation Trust, London, UK
- 700 1_
- $a Passamonti, Francesco $u Department of Medicine and Surgery, University of Insubria, ASST Sette Laghi, Ospedale Di Circolo of Varese, Varese, Italy
- 700 1_
- $a Verga, Luisa $u Azienda Ospedaliera San Gerardo - Monza, Monza, Italy $u Università Milano-Bicocca, Milan, Italy
- 700 1_
- $a Víšek, Benjamin $u University Hospital Hradec Králové, Hradec Králové, Czech Republic
- 700 1_
- $a Ilhan, Osman $u Ankara University, Ankara, Turkey
- 700 1_
- $a Nadali, Gianpaolo $u Policlinico Borgo Roma Verona, Verona, Italy
- 700 1_
- $a Weinbergerová, Barbora $u Department of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic
- 700 1_
- $a Córdoba-Mascuñano, Raúl $u Fundacion Jimenez Díaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain
- 700 1_
- $a Marchetti, Monia $u Hematology and BMT Unit, Azienda Ospedaliera Nazionale SS. Antonio E Biagio E Cesare Arrigo, Alessandria, Italy
- 700 1_
- $a Collins, Graham P $u NIHR Oxford Biomedical Research Centre, Churchill Hospital, Oxford, UK
- 700 1_
- $a Farina, Francesca $u Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milan, Italy
- 700 1_
- $a Cattaneo, Chiara $u ASST-Spedali Civili, Brescia, Italy
- 700 1_
- $a Cabirta, Alba $u Department of Hematology, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain $u Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain
- 700 1_
- $a Gomes-Silva, Maria $u Portuguese Institute of Oncology, Lisbon, Portugal
- 700 1_
- $a Itri, Federico $u San Luigi Gonzaga Hospital - Orbassano, Orbassano, Italy
- 700 1_
- $a van Doesum, Jaap $u University Medical Center Groningen, Groningen, Netherlands
- 700 1_
- $a Ledoux, Marie-Pierre $u ICANS, Strasbourg, France
- 700 1_
- $a Čerňan, Martin $u Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Jakšić, Ozren $u Department of Hematology, University Hospital Dubrava, Zagreb, Croatia
- 700 1_
- $a Duarte, Rafael F $u Hospital Universitario Puerta de Hierro, Majadahonda, Spain
- 700 1_
- $a Magliano, Gabriele $u ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
- 700 1_
- $a Omrani, Ali S $u Communicable Disease Center, Hamad Medical Corporation, Doha, Qatar
- 700 1_
- $a Fracchiolla, Nicola S $u Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
- 700 1_
- $a Kulasekararaj, Austin $u King's College Hospital, London, UK $u King's College London, London, UK
- 700 1_
- $a Valković, Toni $u University Hospital Centre Rijeka, Rijeka, Croatia $u Croatian Cooperative Group for Hematological Diseases (CROHEM), Zagreb, Croatia $u Faculty of Medicine and Faculty of Health Studies, University of Rijeka, Rijeka, Croatia
- 700 1_
- $a Poulsen, Christian Bjørn $u Zealand University Hospital, Roskilde, Roskilde, Denmark
- 700 1_
- $a Machado, Marina $u Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
- 700 1_
- $a Glenthøj, Andreas $u Rigshospitalet, Copenhagen, Denmark
- 700 1_
- $a Stoma, Igor $u Gomel State Medical University, Gomel, Belarus
- 700 1_
- $a Ráčil, Zdeněk $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 700 1_
- $a Piukovics, Klára $u Department of Internal Medicine, Albert Szent-Györgyi Health Center, Faculty of Medicine, University of Szeged, Szeged, Hungary
- 700 1_
- $a Navrátil, Milan $u University Hospital Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Emarah, Ziad $u Oncology Center, Mansoura University, Mansoura, Egypt
- 700 1_
- $a Sili, Uluhan $u Marmara University, Istanbul, Turkey
- 700 1_
- $a Maertens, Johan $u KU Leuven, Leuven, Belgium
- 700 1_
- $a Blennow, Ola $u Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden
- 700 1_
- $a Bergantim, Rui $u 3S-Instituto de Investigação E Inovação Em Saúde, Universidade Do Porto, Porto, Portugal $u Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal $u Clinical Hematology, Centro Hospitalar E Universitário São João, Porto, Portugal $u Clinical Hematology, Faculty of Medicine, University of Porto, Porto, Portugal
- 700 1_
- $a García-Vidal, Carolina $u Hospital Clinic, Barcelona, Spain
- 700 1_
- $a Prezioso, Lucia $u U.O. Ematologia E Centro Trapianti Midollo Osseo, Ospedale Maggiore, Parma, Italy
- 700 1_
- $a Guidetti, Anna $u Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy
- 700 1_
- $a Del Principe, Maria Ilaria $u Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
- 700 1_
- $a Popova, Marina $u Hematology and Transplantation, Raisa Gorbacheva Research Institute of Pediatric Oncology, Pavlov University, St. Petersburg, Russia
- 700 1_
- $a de Jonge, Nick $u Amsterdam UMC, Location VUmc, Amsterdam, Netherlands
- 700 1_
- $a Ormazabal-Vélez, Irati $u Complejo Hospitalario de Navarra, Iruña-Pamplona, Spain
- 700 1_
- $a Fernández, Noemí $u Hospital Universitario Marqués de Valdecilla, Santander, Spain
- 700 1_
- $a Falces-Romero, Iker $u La Paz University Hospital, Madrid, Spain
- 700 1_
- $a Cuccaro, Annarosa $u Hematology Unit, Center for Translational Medicine, Azienda USL Toscana NordOvest, Livorno, Italy
- 700 1_
- $a Meers, Stef $u AZ Klina, Brasschaat, Belgium
- 700 1_
- $a Buquicchio, Caterina $u Ematologia Con Trapianto, Ospedale Dimiccoli Barletta, Barletta, Italy
- 700 1_
- $a Antić, Darko $u Clinic of Hematology, University Clinical Center of Serbia, Belgrade, Serbia $u Faculty of Medicine, University of Belgrade, Belgrade, Serbia
- 700 1_
- $a Al-Khabori, Murtadha $u Sultan Qaboos University Hospital, Muscat, Oman
- 700 1_
- $a García-Sanz, Ramón $u Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain $u IBSAL, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain
- 700 1_
- $a Biernat, Monika M $u Department of Haematology, Blood Neoplasms, and Bone Marrow Transplantation, Wroclaw Medical University, Wrocław, Poland
- 700 1_
- $a Tisi, Maria Chiara $u Cell Therapy and Hematology, San Bortolo Hospital, Vicenza, Italy
- 700 1_
- $a Sal, Ertan $u Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Excellence Center for Medical Mycology (ECMM), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany $u Cologne Excellence Cluster On Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany
- 700 1_
- $a Rahimli, Laman $u Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Excellence Center for Medical Mycology (ECMM), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany $u Cologne Excellence Cluster On Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany
- 700 1_
- $a Čolović, Natasa $u Clinic of Hematology, University Clinical Center of Serbia, Belgrade, Serbia $u Faculty of Medicine, University of Belgrade, Belgrade, Serbia
- 700 1_
- $a Schönlein, Martin $u Department of Oncology, Hematology and Bone Marrow Transplantation With Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- 700 1_
- $a Calbacho, Maria $u Hospital Universitario 12 de Octubre, Madrid, Spain
- 700 1_
- $a Tascini, Carlo $u Azienda Sanitaria Universitaria del Friuli Centrale, Udine, Italy
- 700 1_
- $a Miranda-Castillo, Carolina $u Hospital Rey Juan Carlos, Móstoles, Spain
- 700 1_
- $a Khanna, Nina $u Division of Infectious Diseases and Hospital Epidemiology, Department of Clinical Research, University and University Hospital of Basel, Basel, Switzerland
- 700 1_
- $a Méndez, Gustavo-Adolfo $u Hospital Escuela de Agudos Dr. Ramón Madariaga, Posadas, Argentina
- 700 1_
- $a Petzer, Verena $u Department of Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria
- 700 1_
- $a Novák, Jan $u University Hospital of Královské Vinohrady, Prague, Czech Republic
- 700 1_
- $a Besson, Caroline $u Centre Hospitalier de Versailles, Versailles, France
- 700 1_
- $a Duléry, Rémy $u Service d'Hématologie Clinique Et de Thérapie Cellulaire, Hôpital Saint Antoine, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Inserm UMRs 938, Paris, France
- 700 1_
- $a Lamure, Sylvain $u Departement d'Hematologie Clinique, CHU de Montpellier, UMR-CNRS 5535, Universite de Montpellier, Montpellier, France
- 700 1_
- $a Nucci, Marcio $u Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
- 700 1_
- $a Zambrotta, Giovanni $u Azienda Ospedaliera San Gerardo - Monza, Monza, Italy $u Università Milano-Bicocca, Milan, Italy
- 700 1_
- $a Žák, Pavel $u University Hospital Hradec Králové, Hradec Králové, Czech Republic
- 700 1_
- $a Seval, Guldane Cengiz $u Ankara University, Ankara, Turkey
- 700 1_
- $a Bonuomo, Valentina $u Policlinico Borgo Roma Verona, Verona, Italy
- 700 1_
- $a Mayer, Jiří $u Department of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic
- 700 1_
- $a López-García, Alberto $u Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain
- 700 1_
- $a Sacchi, Maria Vittoria $u Hematology and BMT Unit, Azienda Ospedaliera Nazionale SS. Antonio E Biagio E Cesare Arrigo, Alessandria, Italy
- 700 1_
- $a Booth, Stephen $u NIHR Oxford Biomedical Research Centre, Churchill Hospital, Oxford, UK
- 700 1_
- $a Ciceri, Fabio $u Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milan, Italy
- 700 1_
- $a Oberti, Margherita $u ASST-Spedali Civili, Brescia, Italy
- 700 1_
- $a Salvini, Marco $u Department of Medicine and Surgery, University of Insubria, ASST Sette Laghi, Ospedale Di Circolo of Varese, Varese, Italy
- 700 1_
- $a Izuzquiza, Macarena $u Department of Hematology, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain $u Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain
- 700 1_
- $a Nunes-Rodrigues, Raquel $u Portuguese Institute of Oncology, Lisbon, Portugal
- 700 1_
- $a Ammatuna, Emanuele $u University Medical Center Groningen, Groningen, Netherlands
- 700 1_
- $a Obr, Aleš $u Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Herbrecht, Raoul $u ICANS, Strasbourg, France
- 700 1_
- $a Núñez-Martín-Buitrago, Lucía $u Hospital Universitario Puerta de Hierro, Majadahonda, Spain
- 700 1_
- $a Mancini, Valentina $u ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
- 700 1_
- $a Shwaylia, Hawraa $u National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar
- 700 1_
- $a Sciumè, Mariarita $u Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
- 700 1_
- $a Essame, Jenna $u King's College Hospital, London, UK
- 700 1_
- $a Nygaard, Marietta $u Zealand University Hospital, Roskilde, Roskilde, Denmark
- 700 1_
- $a Batinić, Josip $u Croatian Cooperative Group for Hematological Diseases (CROHEM), Zagreb, Croatia $u University Hospital Centre Zagreb, Zagreb, Croatia $u Faculty of Medicine, University of Zagreb, Zagreb, Croatia
- 700 1_
- $a Gonzaga, Yung $u Hematology Service, Instituto Nacional Do Cancer, Rio de Janeiro, Brazil
- 700 1_
- $a Regalado-Artamendi, Isabel $u Haematology and Haemotherapy Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
- 700 1_
- $a Karlsson, Linda Katharina $u Rigshospitalet, Copenhagen, Denmark
- 700 1_
- $a Shapetska, Maryia $u Scientific and Practical Center for Surgery, Transplantology and Hematology, Minsk, Belarus
- 700 1_
- $a Hanakova, Michaela $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 700 1_
- $a El-Ashwah, Shaimaa $u Oncology Center, Mansoura University, Mansoura, Egypt
- 700 1_
- $a Borbényi, Zita $u Department of Internal Medicine, Albert Szent-Györgyi Health Center, Faculty of Medicine, University of Szeged, Szeged, Hungary
- 700 1_
- $a Çolak, Gökçe Melis $u Marmara University, Istanbul, Turkey
- 700 1_
- $a Nordlander, Anna $u Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden $u Department of Cell Therapy and Allogenic Stem Cell Transplantation (CAST), Karolinska University Hospital, Stockholm, Sweden
- 700 1_
- $a Dragonetti, Giulia $u Hematology, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS - Università Cattolica del Sacro Cuore, Rome, Italy $u Università Cattolica del Sacro Cuore, Rome, Italy
- 700 1_
- $a Maraglino, Alessio Maria Edoardo $u Hematology, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS - Università Cattolica del Sacro Cuore, Rome, Italy $u Università Cattolica del Sacro Cuore, Rome, Italy
- 700 1_
- $a Rinaldi, Amelia $u U.O. Ematologia E Centro Trapianti Midollo Osseo, Ospedale Maggiore, Parma, Italy
- 700 1_
- $a De Ramón-Sánchez, Cristina $u Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain
- 700 1_
- $a Cornely, Oliver A $u Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Excellence Center for Medical Mycology (ECMM), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany $u Chair Translational Research, Cologne Excellence Cluster On Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany $u Clinical Trials Centre Cologne (ZKS Köln), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany $u Center for Molecular Medicine Cologne (CMMC), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany $u German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany
- 710 2_
- $a EPICOVIDEHA working group
- 773 0_
- $w MED00165458 $t Journal of hematology & oncology $x 1756-8722 $g Roč. 14, č. 1 (2021), s. 168
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34649563 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127150213 $b ABA008
- 999 __
- $a ok $b bmc $g 1751038 $s 1154608
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 14 $c 1 $d 168 $e 20211014 $i 1756-8722 $m Journal of hematology & oncology $n J Hematol Oncol $x MED00165458
- GRA __
- $a 2020-8223 $p optics committm (covid-19 unmet medical needs and associated research extension) covid-19 rfp program by gilead science, united states
- LZP __
- $a Pubmed-20220113
